Laboratory Technology / Diagnostic Tests in hall 1 and 3
Here you can find everything that is new in laboratory sector, in which analysis equipment, centrifuges, filtration and water treatment systems, chromatographs, cleaning equipment, drying equipment, homogenizers, cooling systems, microscopes, pH meters, photometers, automatic pipetting and diluting stations, sample distribution systems, analytical balances, microtitre plates, shakers / mixers, automatic dyeing machines, infrared spectrometers, thermostats / temperature measuring instruments, laboratory supplies and furniture are used. You want to know about new trends in the field of diagnostics? the diagnostics sector includes clinical chemistry, immunochemistry / immunology, hematology / histology / cytology, microbiology tests, infection immunology, genetic tests and molecular biology diagnostics.
Scientists have been using fluorescence microscopy to study the inner workings of biological cells and organisms for decades. However, many of these platforms are often too slow to follow the biological action in 3D; and too damaging to the living biological specimens with strong light illumination.
The FDA has granted emergency use authorization (EUA) to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.
The pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is placing unprecedented restrictions on public life and economy. The global research efforts to fill the knowledge gaps regarding the new pathogen and to develop effective therapies are correspondingly large.
People who are at high risk of developing lung cancer are routinely screened with computed tomography (CT), which can detect tumors in the lungs. However, this test has an extremely high rate of false positives. Researchers at MIT have now developed a new approach to early diagnosis of lung cancer: a urine test that can detect the presence of proteins linked to the disease.
Blood test detects over 50 cancer types
Researchers have developed the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease.
Biochemists have created "smart" proteins that function inside human cells by turning genes on and off. The same basic tools that allow computers to function are now being used to control life at the molecular level. The advances have implications for future medicines and synthetic biology.
Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.
Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly. Using the CRISPR/Cas9 gene editing, they have also managed to modify the cells so that they can hide from the immune system to prevent rejection.
A new technique allows researchers to test how the deformation of tiny train track-like cell proteins affects their function. The findings could help clarify the roles of deformed "microtubules" in traumatic brain injuries and in neurological diseases like Parkinson's.
The OncoMX knowledgebase will improve the exploration and research of cancer biomarkers in the context of related evidence, according to a recent article from the George Washington University (GW). The article is published in Clinical Oncology Clinical Cancer Informatics and is part of a special series called "Informatics Tools for Cancer Research and Care."
Using a single atom-thick sheet of graphene to track the electronic signals inherent in biological structures, a team led by Boston College researchers has developed a platform to selectively identify deadly strains of bacteria, an advance that could lead to more accurate targeting of infections with appropriate antibiotics, the team reported in the journal Biosensors and Bioelectronics.
Simon Fraser University researchers will use their pioneering imaging technology - called Mango, for its bright color - to develop coronavirus testing kits. They're among a small set of Canadian researchers who responded to the rapid funding opportunity recently announced by the Canadian Institutes of Health Research (CIHR) to help address COVID-19.
The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia Department of Pathology has developed a novel, accurate coronavirus test that can tell patients if they are infected within about two hours instead of waiting typically days to hear from remote testing facilities.
Take a neural stem cell in the brain: Whether this cell remains a stem cell or differentiates into a fully formed brain cell is ultimately determined by a complex set of molecular messages the cell receives from countless neighbors. Understanding these messages is key for scientists hoping to harness these stem cells to treat neurological conditions like Alzheimer's or Parkinson's.
DNA only persists through replication - naturally or synthetically. While humans need the genetic material to be reproduced in order to replace old or damaged cells, the ability to replicate DNA in a laboratory setting can provide researchers insights into the mechanisms of disease or the platform to develop treatments.
New genetic screening platform using CRISPR technology for targeting thousands of genes in a massively-parallel fashion; accurate and fast method of finding best guides to detect, target, and knockdown specific RNA targets.
A new system combining artificial intelligence (AI) with human knowledge promises faster and more accurate cancer diagnosis. The powerful technology, developed by a team led by engineering researchers at the University of Waterloo, uses digital images of tissue samples to match new cases of suspected cancer with previously diagnosed cases in a database.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation (CDI) has created a test to dramatically reduce the time it takes for diagnosing COVID-19. This is a major advance that will benefit patients, create a more effective triage system in hospitals and better control the spread of disease.
The University of Basel is part of the global search for a drug to fight the rampant coronavirus. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus – with the aim of inhibiting its multiplication.
Researchers at the University of Campinas (UNICAMP) in São Paulo State, Brazil, have developed a computer program that analyzes molecules in blood plasma to search for biomarkers that identify individuals who are at risk of becoming overweight and developing obesity-related diseases.
On 6 March at 11:50 PM EST, the International Space Station resupply mission Space X CRS-20 took off from Cape Canaveral (USA). On board: 250 test tubes from the University of Zurich containing adult human stem cells. These stem cells will develop into bone, cartilage and other organs during the month-long stay in space.
Photoacoustic imaging has gained global attention for capturing images without causing pains or using ionizing radiation. Recently, many researchers have heavily studied on observing deep tissues to apply the photoacoustic imaging to clinical diagnosis and practices.
In a new study published today in Nature Communications, led by Professor Alvaro Mata at the University of Nottingham and Queen Mary University London, researchers have developed a way to 3D print graphene oxide with a protein which can organise into tubular structures that replicate some properties of vascular tissue.
A report in the Journal of Molecular Diagnostics, published by Elsevier, describes a new technique that uses real-time next-generation sequencing (NGS) to analyze tiny amounts of microbial cell-free DNA in the plasma of patients with sepsis, offering the possibility of accurate diagnosis of sepsis-causing agents within a few hours of drawing blood.
Stem cells involved in replenishing human tissues and blood depend on an enzyme known as telomerase to continue working throughout our lives. When telomerase malfunctions, it can lead to both cancer and premature aging conditions. Roughly 90 percent of cancer cells require inappropriate telomerase activity to survive.
Teleflex Medical OEM, a global leader in specialized sutures, braids, and fibers, announces an innovative suture technology: Force Fiber Fusion® Suture. This “two-in- one” construct transitions from...